Dilution profile // every instrument, one screen, from SEC filings

IRADIMED CORP (IRMD)

CIK 1325618 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-3/A on file 2024-05-06
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
LOWwarrants = 2% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+1% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-02-282026-07-31

Latest: 12.8M shares as of Jul 31, 2026 (10-Q).

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 201,600 underlying shares, as reported Jul 21, 2014 (10-Q).

Reported exercise price: $8.13 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $611,000 as of Jul 21, 2014.

Rough fully diluted estimate: 13.0M = 12.8M O/S + 201,600 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Jul 31, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding12.8MJul 31, 2026
+ Warrants (aggregate, as tagged) (if exercised)201,600Jul 21, 2014
Fully diluted estimate13.0M+1.6% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

S-3Apr 3, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

EFFECTIVEMay 8, 2024SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 6, 2024S-3/A registration — capacity to sell shares, not a sale yetS-3/A
REGISTEREDApr 3, 2024S-3 registration — capacity to sell shares, not a sale yetS-3
EFFECTIVESep 3, 2020SEC declared a registration effective — selling can beginEFFECT
REGISTEREDAug 20, 2020S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDDec 18, 2015Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDDec 17, 2015Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EFFECTIVEDec 7, 2015SEC declared a registration effective — selling can beginEFFECT
REGISTEREDDec 3, 2015S-3/A registration — capacity to sell shares, not a sale yetS-3/A
REGISTEREDNov 3, 2015S-3 registration — capacity to sell shares, not a sale yetS-3
REGISTEREDJul 16, 2014S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF
EXECUTEDJul 16, 2014Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full IRMD workspace